Compare DIS & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIS | NVO |
|---|---|---|
| Founded | 1923 | 1923 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.9B | 269.6B |
| IPO Year | 2018 | N/A |
| Metric | DIS | NVO |
|---|---|---|
| Price | $101.14 | $38.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 11 |
| Target Price | ★ $134.73 | $51.00 |
| AVG Volume (30 Days) | 9.8M | ★ 19.9M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 1.48% | ★ 3.19% |
| EPS Growth | ★ 151.84 | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $94,425,000,000.00 | N/A |
| Revenue This Year | $8.22 | N/A |
| Revenue Next Year | $4.27 | $4.39 |
| P/E Ratio | $75.60 | ★ $13.60 |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $80.10 | $35.85 |
| 52 Week High | $124.69 | $82.23 |
| Indicator | DIS | NVO |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 33.90 |
| Support Level | N/A | $35.85 |
| Resistance Level | $115.60 | $50.30 |
| Average True Range (ATR) | 2.05 | 0.88 |
| MACD | -0.25 | 0.16 |
| Stochastic Oscillator | 27.50 | 22.45 |
Disney operates in three global business segments: entertainment, sports, and experiences. Entertainment and experiences both benefit from the firm's ownership of iconic franchises and characters. Entertainment includes the ABC broadcast network, several cable television networks, and the Disney+ and Hulu streaming services. Within the segment, Disney also engages in movie and television production and distribution, with content licensed to movie theaters, other content providers, or, increasingly, kept in-house for use on Disney's own streaming platform and television networks. The sports segment houses the ESPN family of TV networks and streaming services. Experiences contains Disney's theme parks, cruises, and vacation destinations and also engages in merchandise licensing.
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.